Home › Funds › Cambria Investment Management, L.P. › THC
Cambria Investment Management, L.P. position in THC
TENET HEALTHCARE CORP · Health Care
Cambria Investment Management, L.P. reported holding 53,943 shares of THC (TENET HEALTHCARE CORP) in its Q3 2026 13F filing — a position valued at US$13.8M, representing 0.60% of its reported portfolio and ranking #21 among its reported holdings. Cambria Investment Management, L.P. has disclosed THC holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Cambria Investment Management, L.P.'s THC position evolved
Cambria Investment Management, L.P. first disclosed a stake in THC in Q2 2024 at 2,734 shares (US$364K). The position peaked in Q3 2025 at 73,883 shares, worth US$15.0M. Across 10 filings, Cambria Investment Management, L.P. increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 53,943 shares valued at US$13.8M — an increase of 353 shares quarter over quarter.. Notable position changes include a 2891% increase in Q4 2024 (shares rose 7% over the following quarter), a 38% trim in Q4 2025 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 2.73K | $363.70K | New |
| Q3 2024 | 3.32K | $551.62K | Add |
| Q4 2024 | 99.28K | $12.53M | Add |
| Q1 2025 | 90.00K | $12.10M | Reduce |
| Q2 2025 | 78.84K | $13.88M | Reduce |
| Q3 2025 | 73.88K | $15.00M | Reduce |
| Q4 2025 | 46.17K | $9.18M | Reduce |
| Q1 2026 | 47.18K | $8.90M | Add |
| Q2 2026 | 53.59K | $10.03M | Add |
| Q3 2026 | 53.94K | $13.79M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About THC and 13F data
THC (TENET HEALTHCARE CORP) is a Health Care company. 35 other funds we track also report a position in THC — the largest reported positions include Boston Partners (US$1.04B), GLENVIEW CAPITAL MANAGEMENT, LLC (US$418.2M), MANNING & NAPIER ADVISORS LLC (US$153.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding THC
- Boston Partners 4.06M sh · $1.04B · Q3 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 2.24M sh · $418.25M · Q2 2026
- MANNING & NAPIER ADVISORS LLC 562.72K sh · $153.76M · Q3 2026
- EMINENCE CAPITAL, LP 790.30K sh · $149.14M · Q1 2026
More on Cambria Investment Management, L.P.
FAQ
How long has Cambria Investment Management, L.P. held THC?
Cambria Investment Management, L.P. has disclosed THC holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Cambria Investment Management, L.P.'s current position in THC?
As of Q3 2026, Cambria Investment Management, L.P. holds 53.94K shares of THC (TENET HEALTHCARE CORP), valued at $13.79M, representing 0.60% of its reported portfolio and ranking #21.
Has Cambria Investment Management, L.P. been buying or selling THC?
In the latest 13F filing (Q3 2026), Cambria Investment Management, L.P. increased its position in THC. The position peaked in Q3 2025 at 73.88K shares.
Which other funds hold THC?
Other major institutional holders of THC include Boston Partners, GLENVIEW CAPITAL MANAGEMENT, LLC, MANNING & NAPIER ADVISORS LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.